Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Anti-VEGFR2 CAR CD8 lymphocytes |
Trade Name | |
Synonyms | |
Drug Descriptions |
Anti-VEGFR2 CAR CD8 lymphocytes consists of patient's own T-lymphocytes transduced with a recombinant retroviral vector encoding a chimeric T cell receptor specific for KDR (VEGFR2), expanded and reintroduced into the patient. The cells bind to and subsequently lyse VEGFR2-expressing cells (NCI Drug Dictionary). |
DrugClasses | VEGFR2 Immune Cell Therapy 1 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Anti-VEGFR2 CAR CD8 lymphocytes | Anti-VEGFR2 CAR CD8 lymphocytes | 0 | 1 |